Category Archives: Database

Our 2025 database of anti-DLL3 therapeutic programmes in oncology is available for free download here.

🔬 What’s inside?

✅ 6 DLL3-targeted antibody–drug conjugate (ADC) programmes
✅ 7 bispecific and trispecific antibodies
✅ 4 CAR-T & CAR-NK programmes
✅ 1 preclinical DLL3-targeting radiotherapy (RT) programme

❌ 4 discontinued anti-DLL3 clinical trials

Featuring anti-DLL3 programmes addressing solid tumours from leading players, including:

AbbVie, Amgen, Biocytogen, Boehringer Ingelheim, Chugai Pharmaceutical, CStone Pharma, Dragonfly Therapeutics, Harpoon Therapeutics, Hengrui, IDEAYA, Legend Biotech, MediLink Therapeutics, Merck, Molecular Partners, Novartis, Orano Med, Qilu Pharmaceuticals, Roche, Shanghai Fudan-Zhangjiang BioPharma, Suzhou Suncadia Biopharmaceuticals, Stemcentrx, Zai Lab, Zymeworks, and more!

 

Our 2025 Database of Anti-B7-H3/B7-H4 Therapeutic Programmes in oncology is available for free download here.

🔬 What’s inside?
✅ 17 Antibody-drug conjugate (ADC) programmes
✅ 11 Bispecifics & 2 monoclonal antibodies (mAbs) targeting B7-H3 or B7-H4
✅  6 CART-T & CAR-NK programmes
✅  1 radiotherapy (RT) programme (Phase II) based on an anti-B7-H3 mAb

Featuring anti-B7-H3/B7-H4 programmes from leading players, including:

ABL Bio,  Amgen, Anhui Anke Biotechnology, AstraZeneca, BioNTech, Bio-Thera Solutions, Biocytogen, Cullinan Oncology, Daiichi Sankyo, Dartsbio Pharmaceuticals, DualityBio, Five Prime, GSK, Hansoh Pharma, Harbour BioMed, Iksuda Therapeutics, LigaChem Biosciences, Mabstone Biotechnologies, MacroGenics, Maverick Therapeutics, MediLink Therapeutics, Memorial Sloan Kettering Cancer Center, Merck, Mersana Therapeutics, Minghui Pharmaceutical, NextCure, Pfizer, Seagen, Synaffix, lonza, Takeda, Xencor, Y‑mAbs Therapeutics - and more!

 

Our 2025 Database of anti-CCR8 Therapeutic Programmes is available for free download here.

🔬 What’s inside?
✅ 10+ preclinical programmes
✅ 15+ clinical trials
✅ Diverse modalities: mAbs, bispecifics, CAR-T cells, ADCs, and small molecules

Featuring anti-CCR8 programmes from:
AbbVie, Abilita Therapeutics, Inc., Actinium Pharmaceuticals, Inc., Amgen, Bayer, BeiGene, BioNTech SE /Biotheus, Bristol Myers Squibb / ONO PHARMACEUTICAL CO., LTD., Chinese Academy of Sciences, Coherus Oncology / Surface Oncology, DOMAIN Therapeutics, Egle Therapeutics, FibroGen, Inc. / HiFiBiO Therapeutics, Genentech / Roche, Gilead Sciences / Jounce Therapeutics, Inc., Harbour BioMed, HC Biopharma, LaNova Medicines / Sino Biopharmaceutical Limited, Mabwell, Immunophage Biotech Co. Ltd., Oncurious NV, Qilu Pharmaceutical / Sound Biologics, Shionogi & Co., Ltd, Tiannuojiancheng Pharma InnoCare Pharma, University of Science and Technology of China, Zai Lab, Zelgen Biopharmaceuticals, and more!